Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention.
Paolo VerdecchiaPaolo VerdecchiaStefano SavonittoSara CavalliniAndrea SantucciStefano CoiroRocco SclafaniClara RicciniStefano De ServiClaudio CavalliniPublished in: Clinical chemistry and laboratory medicine (2021)
Among patients with ACS or CCS who undergo PCI, higher levels of sCD40L predict an increased risk of acute coronary events and coronary restenosis, but not of mortality.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- acute coronary syndrome
- cardiovascular events
- st segment elevation myocardial infarction
- coronary artery
- coronary artery bypass grafting
- acute myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- liver failure
- aortic stenosis
- risk factors
- drug induced
- coronary artery bypass
- type diabetes
- hepatitis b virus
- cardiovascular disease
- acute respiratory distress syndrome
- aortic valve